Sclerotherapy of hydroceles with polidocanol

Fuse, Hideki; Sakamoto, Michiharu; Fujishiro, Yoshiyuki; Katayama, T.

doi:10.1007/bf02768287

Cited by 5 publications

(6 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the present study the mean hydrocele volume (212.9 ml) is comparable to the mean volume reported in other [3,[5][6][7]. The volume of phenol instilled by us is in accordance with the studies of Shan et al in which volume of phenol instilled was proportional to the volume of the hydrocele [3].…”

Section: Discussionsupporting

confidence: 95%

See 1 more Smart Citation

Sclerotherapy for hydrocele revisited: a prospective randomised study

et al. 2009

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 95%

“…However, Sigurdsson et al and Fuse et al have reported higher success rates (67% and 73%, respectively) with a single session of polidocanol sclerotherapy [4,5]. In group 3 (operative treatment), we were able to achieve a 100% cure rate which is similar to the previously reported results [3,13,14].…”

Section: Discussionsupporting

confidence: 92%

Sclerotherapy for hydrocele revisited: a prospective randomised study

et al. 2009

View full text Add to dashboard Cite

show abstract

“…However, Latif et al [17] in their study among 50 patients of hydrocele found the incidence of bilateral involvement to be 2 % only. Similarly, Fuse et al [18] reported none of their 15 patients to be having bilateral involvement. Agrawal et al [19] also did not report a single case with bilateral involvement.…”

Section: Discussionmentioning

confidence: 89%

Evaluation of the Role of Sodium Tetradecyl Sulfate as a Sclerosant in the Treatment of Primary Hydrocele

et al. 2013

View full text Add to dashboard Cite

The present study was carried out with an aim to perform a prospective study to establish the role of sodium tetradecyl sulfate (3 %) (STDS) as a safe and effective sclerosant in the management of primary hydrocele. Sclerotherapy was performed with 3 % STDS on an outdoor basis. The amount of sclerosant injected depended on the amount of fluid drained. All patients were given prophylactic antibiotics. Patients were clinically reassessed at 1 week, 1 month, 3 months, and 6 months and earlier if complications occur. The data were analyzed using Statistical Package for Social Sciences Version 15.0. The data have been represented as frequencies and percentages. Chi-square test was used to compare the data. A total of 57 patients with primary vaginal hydrocele gave consent for being enrolled in the study. The age of patients ranged from 18 to 65 years with a mean age of 35.72±13.18 years. The success rate at the end of the study was observed to be 84.2 %. As regards patient satisfaction, in present study, in a limited time period of follow up, all the patients who had a successful procedure were satisfied. Overall, sclerotherapy was observed to be a relatively cost-effective (including both direct and indirect costs) procedure with low complications, high satisfaction, and a high success rate within the limited period of follow-up.

show abstract

“…16,17 Similarly, Fuse et al reported none of their 15 patients to be having bilateral -involvement. 18 Agrawal et al also did not report a single case with bilateral involvement. 19 It is difficult to comment whether all these studies had selected patients with unilateral involvement only, as these studies were comparative studies, and hence, in order to rule out any confounding effect, they might have excluded the bilateral involvement.…”

Section: At Fourth Follow-upmentioning

confidence: 96%

Aspiration sclerotherapy: a novel and cost-effective approach to the management of hydroceles in a developing country

2017

View full text Add to dashboard Cite

Background: The present study was carried out with an aim to perform a prospective study to establish the role of sodium tetradecyl sulfate (3 %) (STDS) as a safe and effective sclerosant in the management of primary hydroceles.Methods: Sclerotherapy was performed with 3 % STDS on an outdoor basis. The amount of sclerosant injected depended on the amount of fluid drained. All patients were given prophylactic antibiotics. Patients were clinically reassessed at 1 week, 1 month, 3 months, and 6 months and earlier if complications occurred. All patients were given prophylactic antibiotics. The data were analyzed using Statistical Package for Social Sciences Version 15.0. The data have been represented as frequencies and percentages. Chi-square test was used to compare the data. A total of 57 patients with primary vaginal hydrocele gave consent for being enrolled in the study. The age of patients ranged from 18 to 65 years with a mean age of 35.72±13.18 years.Results: The success rate at the end of the study was observed to be 84.2 %. As regards patient satisfaction, in present study, in a limited time period of follow up, all the patients who had a successful procedure were satisfied.Conclusion: Overall, sclerotherapy was observed to be a relatively cost-effective (including both direct and indirect costs) procedure with low complications, high satisfaction, faster return to work and a high success rate within the limited period of follow-up.

show abstract

Sclerotherapy of hydroceles with polidocanol

Cited by 5 publications

References 15 publications

Sclerotherapy for hydrocele revisited: a prospective randomised study

Sclerotherapy for hydrocele revisited: a prospective randomised study

Evaluation of the Role of Sodium Tetradecyl Sulfate as a Sclerosant in the Treatment of Primary Hydrocele

Aspiration sclerotherapy: a novel and cost-effective approach to the management of hydroceles in a developing country

Contact Info

Product

Resources

About